ID   NTRK2_HUMAN             Reviewed;         822 AA.
AC   Q16620; B1ANZ4; Q16675; Q8WXJ6;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   05-OCT-2010, entry version 128.
DE   RecName: Full=BDNF/NT-3 growth factors receptor;
DE            EC=2.7.10.1;
DE   AltName: Full=GP145-TrkB;
DE            Short=Trk-B;
DE   AltName: Full=Neurotrophic tyrosine kinase receptor type 2;
DE   AltName: Full=TrkB tyrosine kinase;
DE   Flags: Precursor;
GN   Name=NTRK2; Synonyms=TRKB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TRKB).
RC   TISSUE=Hippocampus;
RX   MEDLINE=95309922; PubMed=7789988; DOI=10.1016/0888-7543(95)80055-Q;
RA   Nakagawara A., Liu X.-G., Ikegaki N., White P.S., Yamashiro D.J.,
RA   Nycum L.M., Biegel J.A., Brodeur G.M.;
RT   "Cloning and chromosomal localization of the human TRK-B tyrosine
RT   kinase receptor gene (NTRK2).";
RL   Genomics 25:538-546(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS TRKB AND TRKB-T1).
RC   TISSUE=Brain;
RX   MEDLINE=95123473; PubMed=7823156;
RA   Shelton D.L., Sutherland J., Gripp J., Camerato T., Armanini M.P.,
RA   Phillips H.S., Carroll K., Spencer S.D., Levinson A.D.;
RT   "Human trks: molecular cloning, tissue distribution, and expression of
RT   extracellular domain immunoadhesins.";
RL   J. Neurosci. 15:477-491(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TRKB-T1).
RC   TISSUE=Hippocampus;
RX   MEDLINE=95022162; PubMed=7936202; DOI=10.1016/0306-4522(94)90507-X;
RA   Allen S.J., Dawbarn D., Eckford S.D., Wilcock G.K., Ashcroft M.,
RA   Colebrook S.M., Feeney R., Macgowan S.H.;
RT   "Cloning of a non-catalytic form of human trkB and distribution of
RT   messenger RNA for trkB in human brain.";
RL   Neuroscience 60:825-834(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS TRKB; TRKB-T1 AND TRKB-T-SHC).
RX   MEDLINE=21656983; PubMed=11798182; DOI=10.1006/bbrc.2001.6301;
RA   Stoilov P., Castren E., Stamm S.;
RT   "Analysis of the human TrkB gene genomic organization reveals novel
RT   TrkB isoforms, unusual gene length, and splicing mechanism.";
RL   Biochem. Biophys. Res. Commun. 290:1054-1065(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TRKB-T1), AND VARIANT ARG-309.
RA   Steinbeck J.A., Thomsen S., Wessig J., Leypoldt F., Lewerenz J.,
RA   Methner A.;
RT   "Full length truncated TrkB sequence identified in a screen for genes
RT   regulated by ischemic preconditioning.";
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM TRKB-T1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   DISULFIDE BONDS.
RX   MEDLINE=96004804; PubMed=7574684; DOI=10.1006/abbi.1995.1460;
RA   Haniu M., Talvenheimo J., Le J., Katta V., Welcher A., Rohde M.F.;
RT   "Extracellular domain of neurotrophin receptor trkB: disulfide
RT   structure, N-glycosylation sites, and ligand binding.";
RL   Arch. Biochem. Biophys. 322:256-264(1995).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-67; ASN-121 AND ASN-254,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 283-385.
RX   PubMed=10388563; DOI=10.1006/jmbi.1999.2816;
RA   Ultsch M.H., Wiesmann C., Simmons L.C., Henrich J., Yang M.,
RA   Reilly D., Bass S.H., de Vos A.M.;
RT   "Crystal structures of the neurotrophin-binding domain of TrkA, TrkB
RT   and TrkC.";
RL   J. Mol. Biol. 290:149-159(1999).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 284-383.
RX   PubMed=11738045; DOI=10.1016/S0969-2126(01)00681-5;
RA   Banfield M.J., Naylor R.L., Robertson A.G., Allen S.J., Dawbarn D.,
RA   Brady R.L.;
RT   "Specificity in Trk receptor:neurotrophin interactions: the crystal
RT   structure of TrkB-d5 in complex with neurotrophin-4/5.";
RL   Structure 9:1191-1199(2001).
RN   [12]
RP   VARIANT [LARGE SCALE ANALYSIS] PHE-138.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [13]
RP   VARIANTS ILE-697; GLY-699 AND CYS-718.
RX   PubMed=18293376; DOI=10.1002/humu.20707;
RA   Marchetti A., Felicioni L., Pelosi G., Del Grammastro M.,
RA   Fumagalli C., Sciarrotta M., Malatesta S., Chella A., Barassi F.,
RA   Mucilli F., Camplese P., D'Antuono T., Sacco R., Buttitta F.;
RT   "Frequent mutations in the neurotrophic tyrosine receptor kinase gene
RT   family in large cell neuroendocrine carcinoma of the lung.";
RL   Hum. Mutat. 29:609-616(2008).
CC   -!- FUNCTION: Receptor for brain-derived neurotrophic factor (BDNF),
CC       neurotrophin-3 and neurotrophin-4/5 but not nerve growth factor
CC       (NGF). Involved in the development and/or maintenance of the
CC       nervous system. This is a tyrosine-protein kinase receptor. Known
CC       substrates for the TRK receptors are SHC1, PI-3 kinase, and PLC-
CC       gamma-1.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Exists in a dynamic equilibrium between monomeric (low
CC       affinity) and dimeric (high affinity) structures. Binds SH2B2.
CC       Interacts with SQSTM1 and KIDINS220 (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist;
CC       Name=TrkB;
CC         IsoId=Q16620-1; Sequence=Displayed;
CC       Name=TrkB-T1;
CC         IsoId=Q16620-2; Sequence=VSP_002901, VSP_002902;
CC       Name=TrkB-T-Shc;
CC         IsoId=Q16620-3; Sequence=VSP_002903, VSP_002904;
CC   -!- TISSUE SPECIFICITY: Isoform TrkB is widely expressed, mainly in
CC       the nervous tissue. In the CNS, expression is observed in the
CC       cerebral cortex, hippocampus, thalamus, choroid plexus, granular
CC       layer of the cerebellum, brain stem, and spinal cord. In the
CC       peripheral nervous system, it is expressed in many cranial
CC       ganglia, the ophtalmic nerve, the vestibular system, multiple
CC       facial structures, the submaxillary glands, and dorsal root
CC       ganglia. Isoform TrkB-T1 is expressed in multiple tissues, mainly
CC       in brain, pancreas, kidney and heart. Isoform TrkB-T-Shc is
CC       predominantly expressed in brain.
CC   -!- PTM: Ligand-mediated auto-phosphorylation.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Insulin receptor subfamily.
CC   -!- SIMILARITY: Contains 2 Ig-like C2-type (immunoglobulin-like)
CC       domains.
CC   -!- SIMILARITY: Contains 2 LRR (leucine-rich) repeats.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NTRK2ID41589ch9q21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U12140; AAC51371.1; -; mRNA.
DR   EMBL; S76473; AAB33109.1; -; mRNA.
DR   EMBL; S76474; AAB33110.1; -; mRNA.
DR   EMBL; X75958; CAA53571.1; -; mRNA.
DR   EMBL; AF410900; AAL67966.1; -; mRNA.
DR   EMBL; AF508964; AAM77876.1; -; mRNA.
DR   EMBL; AL390777; CAH72194.1; -; Genomic_DNA.
DR   EMBL; AL596132; CAH72194.1; JOINED; Genomic_DNA.
DR   EMBL; AL596132; CAH72313.1; -; Genomic_DNA.
DR   EMBL; AL390777; CAH72313.1; JOINED; Genomic_DNA.
DR   EMBL; BC031835; AAH31835.1; -; mRNA.
DR   IPI; IPI00003366; -.
DR   IPI; IPI00179433; -.
DR   IPI; IPI00478527; -.
DR   PIR; A56853; A56853.
DR   PIR; I73631; I73631.
DR   RefSeq; NP_001007098.1; -.
DR   RefSeq; NP_001018074.1; -.
DR   RefSeq; NP_001018076.1; -.
DR   UniGene; Hs.494312; -.
DR   PDB; 1HCF; X-ray; 2.70 A; X/Y=286-383.
DR   PDB; 1WWB; X-ray; 2.10 A; X=283-385.
DR   PDBsum; 1HCF; -.
DR   PDBsum; 1WWB; -.
DR   ProteinModelPortal; Q16620; -.
DR   SMR; Q16620; 32-193, 90-284, 203-374, 532-811.
DR   DIP; DIP-5720N; -.
DR   STRING; Q16620; -.
DR   PhosphoSite; Q16620; -.
DR   PRIDE; Q16620; -.
DR   Ensembl; ENST00000323115; ENSP00000314586; ENSG00000148053.
DR   Ensembl; ENST00000376213; ENSP00000365386; ENSG00000148053.
DR   GeneID; 4915; -.
DR   KEGG; hsa:4915; -.
DR   UCSC; uc004anx.1; human.
DR   UCSC; uc004aoa.1; human.
DR   CTD; 4915; -.
DR   GeneCards; GC09P087283; -.
DR   HGNC; HGNC:8032; NTRK2.
DR   HPA; CAB010346; -.
DR   HPA; HPA007637; -.
DR   MIM; 600456; gene+phenotype.
DR   PharmGKB; PA31818; -.
DR   eggNOG; prNOG08108; -.
DR   HOVERGEN; HBG056735; -.
DR   PhylomeDB; Q16620; -.
DR   BRENDA; 2.7.10.1; 247.
DR   Pathway_Interaction_DB; trkrpathway; Neurotrophic factor-mediated Trk receptor signaling.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   NextBio; 18915; -.
DR   ArrayExpress; Q16620; -.
DR   Bgee; Q16620; -.
DR   CleanEx; HS_NTRK2; -.
DR   Genevestigator; Q16620; -.
DR   GermOnline; ENSG00000148053; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005030; F:neurotrophin receptor activity; IEA:InterPro.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kin...; IEA:EC.
DR   GO; GO:0007190; P:activation of adenylate cyclase activity; EXP:Reactome.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; EXP:Reactome.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000372; LRR-contain_N.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR020455; Tyr_kin_neurotrophic_rcpt_2.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR020777; Tyr_prot_kinase_NGF_rcpt.
DR   InterPro; IPR002011; Tyr_prot_kinase_rcpt_2_CS.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 2.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   PANTHER; PTHR23256:SF284; Tyr_prot_kinase_NGF_rcpt; 1.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF01462; LRRNT; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR01939; NTKRECEPTOR.
DR   PRINTS; PR01941; NTKRECEPTOR2.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00408; IGc2; 1.
DR   SMART; SM00082; LRRCT; 1.
DR   SMART; SM00013; LRRNT; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00239; RECEPTOR_TYR_KIN_II; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Developmental protein; Differentiation; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Kinase; Leucine-rich repeat; Membrane;
KW   Neurogenesis; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Receptor; Repeat; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL        1     31
FT   CHAIN        32    822       BDNF/NT-3 growth factors receptor.
FT                                /FTId=PRO_0000016727.
FT   TOPO_DOM     32    430       Extracellular (Potential).
FT   TRANSMEM    431    454       Helical; (Potential).
FT   TOPO_DOM    455    822       Cytoplasmic (Potential).
FT   REPEAT       72     93       LRR 1.
FT   REPEAT       96    117       LRR 2.
FT   DOMAIN      197    282       Ig-like C2-type 1.
FT   DOMAIN      295    365       Ig-like C2-type 2.
FT   DOMAIN      538    807       Protein kinase.
FT   NP_BIND     544    552       ATP (By similarity).
FT   ACT_SITE    676    676       Proton acceptor (By similarity).
FT   BINDING     572    572       ATP (By similarity).
FT   SITE        516    516       Interaction with SHC1 (By similarity).
FT   SITE        817    817       Interaction with PLC-gamma-1 (By
FT                                similarity).
FT   MOD_RES     516    516       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     702    702       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     706    706       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     707    707       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     817    817       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   CARBOHYD     67     67       N-linked (GlcNAc...).
FT   CARBOHYD     95     95       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    121    121       N-linked (GlcNAc...).
FT   CARBOHYD    178    178       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    205    205       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    241    241       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    254    254       N-linked (GlcNAc...).
FT   CARBOHYD    280    280       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    325    325       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    338    338       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    412    412       N-linked (GlcNAc...) (Potential).
FT   DISULFID     32     38
FT   DISULFID     36     45
FT   DISULFID    152    176
FT   DISULFID    154    194
FT   DISULFID    218    266
FT   DISULFID    302    345
FT   VAR_SEQ     467    477       PASVISNDDDS -> FVLFHKIPLDG (in isoform
FT                                TrkB-T1).
FT                                /FTId=VSP_002901.
FT   VAR_SEQ     478    822       Missing (in isoform TrkB-T1).
FT                                /FTId=VSP_002902.
FT   VAR_SEQ     529    537       FVQHIKRHN -> WPRGSPKTA (in isoform TrkB-
FT                                T-Shc).
FT                                /FTId=VSP_002903.
FT   VAR_SEQ     538    822       Missing (in isoform TrkB-T-Shc).
FT                                /FTId=VSP_002904.
FT   VARIANT     138    138       L -> F (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041470.
FT   VARIANT     309    309       G -> R.
FT                                /FTId=VAR_016320.
FT   VARIANT     338    338       N -> Y (in dbSNP:rs1047856).
FT                                /FTId=VAR_011973.
FT   VARIANT     545    545       G -> V (in dbSNP:rs1075108).
FT                                /FTId=VAR_049715.
FT   VARIANT     697    697       M -> I (in a lung carcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_046518.
FT   VARIANT     699    699       R -> G (in a lung carcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_046519.
FT   VARIANT     718    718       R -> C (in a lung carcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_046520.
FT   STRAND      285    292
FT   STRAND      296    311
FT   STRAND      314    319
FT   STRAND      322    324
FT   STRAND      328    337
FT   STRAND      339    350
FT   HELIX       353    355
FT   STRAND      357    364
FT   STRAND      369    376
SQ   SEQUENCE   822 AA;  91999 MW;  2FEB9159948F0D13 CRC64;
     MSSWIRWHGP AMARLWGFCW LVVGFWRAAF ACPTSCKCSA SRIWCSDPSP GIVAFPRLEP
     NSVDPENITE IFIANQKRLE IINEDDVEAY VGLRNLTIVD SGLKFVAHKA FLKNSNLQHI
     NFTRNKLTSL SRKHFRHLDL SELILVGNPF TCSCDIMWIK TLQEAKSSPD TQDLYCLNES
     SKNIPLANLQ IPNCGLPSAN LAAPNLTVEE GKSITLSCSV AGDPVPNMYW DVGNLVSKHM
     NETSHTQGSL RITNISSDDS GKQISCVAEN LVGEDQDSVN LTVHFAPTIT FLESPTSDHH
     WCIPFTVKGN PKPALQWFYN GAILNESKYI CTKIHVTNHT EYHGCLQLDN PTHMNNGDYT
     LIAKNEYGKD EKQISAHFMG WPGIDDGANP NYPDVIYEDY GTAANDIGDT TNRSNEIPST
     DVTDKTGREH LSVYAVVVIA SVVGFCLLVM LFLLKLARHS KFGMKGPASV ISNDDDSASP
     LHHISNGSNT PSSSEGGPDA VIIGMTKIPV IENPQYFGIT NSQLKPDTFV QHIKRHNIVL
     KRELGEGAFG KVFLAECYNL CPEQDKILVA VKTLKDASDN ARKDFHREAE LLTNLQHEHI
     VKFYGVCVEG DPLIMVFEYM KHGDLNKFLR AHGPDAVLMA EGNPPTELTQ SQMLHIAQQI
     AAGMVYLASQ HFVHRDLATR NCLVGENLLV KIGDFGMSRD VYSTDYYRVG GHTMLPIRWM
     PPESIMYRKF TTESDVWSLG VVLWEIFTYG KQPWYQLSNN EVIECITQGR VLQRPRTCPQ
     EVYELMLGCW QREPHMRKNI KGIHTLLQNL AKASPVYLDI LG
//
